Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Falguni S, Vyas"'
Publikováno v:
Chemical research in toxicology. 33(9)
We have previously shown that phenyl saligenin phosphate (PSP), an organophosphorus compound which is classed as a weak inhibitor of acetylcholinesterase, triggered cytotoxicity in mitotic and differentiated H9c2 cardiomyoblasts. The aim of this stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56e8fc2a1edaa1d7fea4961f13d7c5b8
https://pubmed.ncbi.nlm.nih.gov/32786544
https://pubmed.ncbi.nlm.nih.gov/32786544
Publikováno v:
European Journal of Pharmacology. 819:144-160
Pharmacologically-induced pre- and post-conditioning represent attractive therapeutic strategies to reduce ischaemia/reperfusion injury during cardiac surgery and following myocardial infarction. We have previously reported that transglutaminase 2 (T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::135c79035ff23421878fa6647a188a42
https://doi.org/10.1016/j.ejphar.2017.11.049
https://doi.org/10.1016/j.ejphar.2017.11.049
Autor:
David J. Boocock, Philip L.R. Bonner, Falguni S. Vyas, Alan J. Hargreaves, John M. Dickenson, Clare Coveney
Publikováno v:
Biochemical Pharmacology. 107:41-58
The regulation of tissue transglutaminase (TG2) activity by the GPCR family is poorly understood. In this study, we investigated the modulation of TG2 activity by the A1 adenosine receptor in cardiomyocyte-like H9c2 cells. H9c2 cells were lysed follo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::109985d18a3d15886cd46f27e9c1d14e
https://doi.org/10.1016/j.bcp.2016.03.016
https://doi.org/10.1016/j.bcp.2016.03.016
Publikováno v:
European journal of pharmacology. 819
Pharmacologically-induced pre- and post-conditioning represent attractive therapeutic strategies to reduce ischaemia/reperfusion injury during cardiac surgery and following myocardial infarction. We have previously reported that transglutaminase 2 (T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::77567d6313ff8d9a30c73ea4fd3c87cc
https://pubmed.ncbi.nlm.nih.gov/29208472
https://pubmed.ncbi.nlm.nih.gov/29208472
Autor:
John M. Dickenson, Carl P. Nelson, Alan J. Hargreaves, Falguni S. Vyas, David J. Boocock, Fiona Freeman
Tissue transglutaminase 2 (TG2) is modulated by protein kinase A (PKA) mediated phosphorylation: however, the precise mechanism(s) of its modulation by G-protein coupled receptors coupled to PKA activation are not fully understood. In the current stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::449fa2977fb6339cf189a08caa3d4839
https://irep.ntu.ac.uk/id/eprint/31484/1/PubSub9005_Nelson.pdf
https://irep.ntu.ac.uk/id/eprint/31484/1/PubSub9005_Nelson.pdf
Autor:
Falguni S, Vyas, Carl P, Nelson, Fiona, Freeman, David J, Boocock, Alan J, Hargreaves, John M, Dickenson
Publikováno v:
European journal of pharmacology. 813
Tissue transglutaminase 2 (TG2) is modulated by protein kinase A (PKA) mediated phosphorylation: however, the precise mechanism(s) of its modulation by G-protein coupled receptors coupled to PKA activation are not fully understood. In the current stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4a5d398c18fb5574dc22ad3e7a41ffdf
https://pubmed.ncbi.nlm.nih.gov/28754379
https://pubmed.ncbi.nlm.nih.gov/28754379